The effects of temperature and scopolamine on N-methyl-D-aspartate antagonist-induced neuronal necrosis in the rat

Neuroscience

Volumn 90, Issue 1, 1999, Pages 87-94

  Colbourne, F ^a   Rakic D ^a   Auer, R N ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Hyperthermia; Hypothermia; MK 801; NMDA antagonist; Scopolamine; Sex difference

Indexed keywords

DIZOCILPINE MALEATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SCOPOLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CINGULATE GYRUS; CONTROLLED STUDY; DENTATE GYRUS; ENTORHINAL CORTEX; FEMALE; HEAT SENSITIVITY; MALE; NERVE CELL NECROSIS; NEUROMODULATION; NEUROTOXICITY; NONHUMAN; OLFACTORY CORTEX; PRIORITY JOURNAL; RAT; SEX DIFFERENCE;

ANIMALS; CEREBRAL CORTEX; DIZOCILPINE MALEATE; ENTORHINAL CORTEX; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GYRUS CINGULI; HEAT; HYPOTHERMIA, INDUCED; MALE; N-METHYLASPARTATE; NECROSIS; NEURONS; NEUROPROTECTIVE AGENTS; OLFACTORY PATHWAYS; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; SCOPOLAMINE; SEX CHARACTERISTICS; STEREOTAXIC TECHNIQUES;

EID: 0032974526     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00375-3     Document Type: Article

References (53)

1. Akinci M.K., Johnston G.A. Sex differences in acute swim stress-induced changes in the binding of MK-801 to the NMDA subclass of glutamate receptors in mouse forebrain. J. Neurochem. 61:1993;2290-2293.
2. Allen H.L., Iversen L.L. Phencyclidine, dizocilpine, and cerebrocortical neurons. Science. 247:1990;221.
3. Auer R.N. The effect of age and sex on MK-801 induced neuronal necrosis. Stroke. 27:1996;743-746.
4. Auer R.N., Coulter K.C. The nature and time course of neuronal vacuolation induced by the NMDA antagonist MK-801. Acta neuropath., Berlin. 87:1994;1-7.
5. Auer R.N., Kalimo H., Olsson Y., Siesjö B.K. The temporal evolution of hypoglycemic brain damage. I. Light and electron microscopic findings in the rat cerebral cortex. Acta neuropath., Berlin. 67:1985;13-24.
6. Auer R.N., Kalimo H., Olsson Y., Siesjö B.K. The temporal evolution of hypoglycemic brain damage. II. Light and electron microscopic findings in the rat hippocampus. Acta neuropath., Berlin. 67:1985;25-36.
7. Avoli M., Olivier A. Bursting in human epileptogenic neocortex is depressed by an N-methyl-D-aspartate antagonist. Neurosci. Lett. 76:1987;249-254.
8. Blanchard D.C., Blanchard R.J., Carobrez A. de P., Veniegas R., Rodgers R.J., Shepherd J.K. MK-801 produces a reduction in anxiety-related antipredator defensiveness in male and female rats and a gender-dependent increase in locomotor behavior. Psychopharmacology, Berlin. 108:1992;352-362.
9. Bowyer J.F., Davies D.L., Schmued L., Broening H.W., Newport G.D., Slikker W. Jr., Holson R.R. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J. Pharmac. exp. Ther. 268:1994;1571-1580.
10. Buchan A., Pulsinelli W.A. Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia. J. Neurosci. 10:1990;311-316.
11. Clark S.M., Lipton J.M. Effects of diazepam on body temperature of the aged squirrel monkey. Brain Res. Bull. 7:1981;5-9.
12. Colbourne F., Corbett D. Delayed and prolonged post-ischemic hypothermia is neuroprotective in the gerbil. Brain Res. 654:1994;265-272.
13. Colbourne F., Corbett D. Delayed postischemic hypothermia: a six month survival study using behavioral and histologic assessments of neuroprotection. J. Neurosci. 15:1995;7250-7260.
14. Colbourne F., Sutherland G.R., Auer R.N. An automated system for regulating brain temperature in awake and freely moving rats. J. Neurosci. Meth. 67:1996;185-190.
15. Colbourne F., Sutherland G., Corbett D. Postischemic hypothermia: a critical appraisal with implications for clinical treatment. Molec. Neurobiol. 14:1997;171-201.
16. Colbourne F., Sutherland G.R., Auer R.N. New features of delayed neuronal death in gerbils treated with prolonged postischemic hypothermia. Soc. Neurosci. Abstr. 23:1997;1917.
17. Corbett D., Evans S., Thomas C., Wang D., Jonas R. MK-801 reduces cerebral ischemic injury by inducing hypothermia. Brain Res. 514:1990;300-304.
18. Dietrich W.D. The importance of brain temperature in cerebral injury. J. Neurotrauma. 9:1992;S475-S485.
19. Dietrich W.D., Busto R., Alonso O., Globus M.Y.-T., Ginsberg M.D. Intraischemic but not postischemic brain hypothermia protects chronically following global forebrain ischemia in rats. J. cerebr. Blood Flow Metab. 13:1993;541-549.
20. Dietrich W.D., Lin B., Globus M.Y.-T., Green E.J., Ginsberg M.D., Busto R. Effect of delayed MK-801 (Dizocilpine) treatment with or without immediate postischemic hypothermia on chronic neuronal survival after global forebrain ischemia in rats. J. cerebr. Blood Flow Metab. 15:1995;960-968.
21. Douglas B.G., Dagirmanjian R. The effects of magnesium deficiency on ketamine sleeping times in the rat. Br. J. Anaesth. 47:1975;336-340.
22. Fix A.S., Horn J.W., Wightman K.A., Johnson C.A., Long G.G., Storts R.W., Farber N., Wozniak D.F., Olney J.W. Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex. Expl Neurol. 123:1993;204-215.
23. Fix A.S., Horn J.W., Truex L.L., Smith R.A., Gomez E. Neuronal vacuole formation in the rat posterior cingulate/retrosplenial cortex after treatment with the N-methyl-D-aspartate (NMDA) antagonist MK-801 (dizocilpine maleate). Acta neuropath., Berlin. 88:1994;511-519.
24. Fix A.S., Wozniak D.F., Truex L.L., McEwen M., Miller J.P., Olney J.W. Quantitative analysis of factors influencing neuronal necrosis induced by MK-801 in the rat posterior cingulate/retrosplenial cortex. Brain Res. 696:1995;194-204.
25. Geddes J.W., Chang-Chui H., Cooper S.M., Lott I.T., Cotman C.W. Density and distribution of NMDA receptors in the human hippocampus in Alzheimer's disease. Brain Res. 399:1986;156-161.
26. Gill R., Foster A.C., Woodruff G.N. Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil. J. Neurosci. 7:1987;3343-3349.
27. Gill R., Foster A.C., Woodruff G.N. MK-801 is neuroprotective in gerbils when administered in the post-ischaemic period. Neuroscience. 25:1988;847-855.
28. Ginsberg M.D., Sternau L.L., Globus M.Y., Dietrich W.D., Busto R. Therapeutic modulation of brain temperature: relevance to ischemic brain injury. Cerebrovasc. Brain Metab. Rev. 4:1992;189-225.
29. 3H]glutamate binding. J. Neurochem. 48:1987;543-551.
30. Greenamyre J.T., Eller R.V., Zhang Z., Ovadia A., Kurlan R., Gash D.M. Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease [comment]. Ann. Neurol. 35:1994;655-661.
31. Honack D., Loscher W. Sex differences in NMDA receptor mediated responses in rats. Brain Res. 620:1993;167-170.
32. Horváth Z.C., Czopf J., Buzsáki G. MK-801-induced neuronal damage in rats. Brain Res. 753:1997;181-195.
33. Ingvar M., Morgan P.F., Auer R.N. The nature and timing of excitotoxic neuronal necrosis in the cerebral cortex, hippocampus and thalamus due to flurothyl-induced status epilepticus. Acta neuropath., Berlin. 75:1988;362-369.
34. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239:1982;57-69.
35. Kornhuber J., Quack G. Cerebrospinal fluid and serum concentrations of the N-methyl-D-aspartate (NMDA) receptor antagonist memantine in man. Neurosci. Lett. 195:1995;137-139.
36. Kurumaji A., McCulloch J. Effects of MK-801 upon local cerebral glucose utilisation in conscious rats and in rats anaesthetised with halothane. J. cerebr. Blood Flow Metab. 9:1989;786-794.
37. Kurumaji A., Nehls D.G., Park C.K., McCulloch J. Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use. Brain Res. 496:1989;268-284.
38. Maher J., Hachinski V. Hypothermia as a potential treatment of cerebral ischemia. Cerebrovasc. Brain Metab. Rev. 5:1993;277-300.
39. 3H]TCP binding in Alzheimer's disease. Neurosci. Lett. 74:1987;371-376.
40. Nabeshima T., Yamaguchi K., Yamada K., Hiramatsu M., Kuwabara Y., Furukawa H., Kameyama T. Sex-dependent differences in the pharmacological actions and pharmacokinetics of phencyclidine in rats. Eur. J. Pharmac. 97:1984;217-227.
41. Olney J.W., Labruyere J., Price M.T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science. 244:1989;1360-1362.
42. Olney J.W., Labruyere J., Wang G., Wozniak D.F., Price M.T., Sesma M.A. NMDA antagonist neurotoxicity: mechanism and prevention. Science. 254:1991;1515-1518.
43. Palmer G.C., Murray R.J., Wilson T.C., Eisman M.S., Ray R.K., Griffith R.C., Napier J.J., Fedorchuk M., Stagnitto M.L., Garske G.E. Biological profiles of the metabolites and potential metabolites of the anti-convulsant remacemide. Epilepsy Res. 12:1992;9-20.
44. Palmer G.C., Clark B., Hutchison J.B. Antiepileptic and neuroprotective potential of remacemide hydrochloride. Drugs Future. 18:1993;1021-1042.
45. Palmer G.C., Cregan E.C., Borrelli A.R., Harris E.W., Stagnitto M.L., Colombo P., Kaiser F.C., Murray R.J., Griffith R.C., Strand J.C. Neuroprotective actions of 2-amino-N-(1,2-diphenylethyl)-acetamide hydrochloride (FPL 13950) in animal models of hypoxia and global ischemia. J. Pharmac. exp. Ther. 274:1995;991-1000.
46. Parsons C.G., Quack G., Bresink I., Baran L., Przegalinski E., Kostowski W., Krzascik P., Hartmann S., Danysz W. Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo. Neuropharmacology. 34:1995;1239-1258.
47. Paxinos G. and Watson C. (1982) The Rat Brain in Stereotaxic Coordinates. Academic, New York.
48. Pulsinelli W.A., Brierley J.B., Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol. 11:1982;491-498.
49. Schwartz R.D., Yu X., Katzman M.R., Hayden-Hixson D.M., Perry J.M. Diazepam, given postischemia, protects selectively vulnerable neurons in the rat hippocampus and striatum. J. Neurosci. 15:1995;529-539.
50. Steele J.E., Palmer A.M., Stratmann G.C., Bowen D.M. The N-methyl-D-aspartate receptor complex in Alzheimer's disease: reduced regulation by glycine but not zinc. Brain Res. 500:1989;369-373.
51. Whishaw I.Q., Auer R.N. Immediate and long-lasting effects of MK-801 on motor activity, spatial navigation in a swimming pool and EEG in the rat. Psychopharmacology, Berlin. 98:1989;500-507.
52. Wixson S.K., White W.J., Hughes H.C. Jr., Lang C.M., Marshall W.K. The effects of pentobarbital, fentanyl-droperidol, ketamine-xylazine and ketamine-diazepam on core and surface body temperature regulation in adult male rats. Lab. Anim. Sci. 37:1987;743-749.
53. Wozniak D.F., Brosnan-Watters G., Nardi A., McEwen M., Corso T.D., Olney J.W., Fix A.S. MK-801 neurotoxicity in male mice: histologic effects and chronic impairment in spatial learning. Brain Res. 707:1996;165-179.